Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
27.30
Dollar change
+0.17
Percentage change
0.63
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y- Shs Outstand Perf Week-2.01%
SponsorTema ETF Type Tagsequity Return% 3Y- Total Holdings48 Perf Month-0.51%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM31.09M Perf Quarter-1.62%
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y5.73%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tags- Flows% 1M69.17% 52W Range21.46 - 29.16 Perf YTD3.42%
Dividend TTM0.13 (0.49%) ESG Type Tags- Flows% 3M71.79% 52W High-6.38% Beta-
Dividend Ex-DateDec 13, 2023 Dividend Type Sector/Theme Flows% YTD74.28% 52W Low27.23% ATR (14)0.66
Expense0.75% Structure Type Region Flows% 1Y RSI (14)51.01 Volatility3.43% 2.46%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume5.10 Prev Close27.13
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume13.27K Price27.30
SMA200.28% SMA501.52% SMA2006.06% Trades Volume67,659 Change0.63%
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.